Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes
Authors
Keywords
Mouse models, Diabetes mellitus, Antioxidants, Catalases, Kidneys, Blood sugar, Body weight, Glucose-6-phosphate dehydrogenase deficiency
Journal
PLoS One
Volume 13, Issue 7, Pages e0200249
Publisher
Public Library of Science (PLoS)
Online
2018-07-07
DOI
10.1371/journal.pone.0200249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of soluble and membrane-bound dipeptidyl peptidase-4 in diabetic nephropathy
- (2017) Ahmed A Hasan et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway
- (2017) Esther Civantos et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats
- (2016) Masako Uchii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats
- (2016) Ayman Mahmoud et al. Drug Design Development and Therapy
- The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy
- (2016) Nadine Dietrich et al. PLoS One
- Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
- (2016) Maaike Waasdorp et al. Scientific Reports
- Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
- (2015) Mark E. Cooper et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways
- (2015) Rania M. Abdelsalam et al. JOURNAL OF NEUROCHEMISTRY
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease
- (2014) Robert C. Stanton AMERICAN JOURNAL OF KIDNEY DISEASES
- The Basic Biology of Redoxosomes in Cytokine-Mediated Signal Transduction and Implications for Disease-Specific Therapies
- (2014) Netanya Y. Spencer et al. BIOCHEMISTRY
- Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
- (2014) Keizo Kanasaki et al. DIABETES
- Linagliptin Blocks Renal Damage in Type 1 Diabetic Rats by Suppressing Advanced Glycation End Products-Receptor Axis
- (2014) S. Nakashima et al. HORMONE AND METABOLIC RESEARCH
- Vildagliptin Ameliorates Oxidative Stress and Pancreatic Beta Cell Destruction in Type 1 Diabetic Rats
- (2013) Danielle de Lima Ávila et al. ARCHIVES OF MEDICAL RESEARCH
- Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats
- (2013) Wulan Bao et al. JOURNAL OF VASCULAR SURGERY
- Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
- (2013) William B. White et al. NEW ENGLAND JOURNAL OF MEDICINE
- Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
- (2013) Benjamin M. Scirica et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes
- (2012) Mona Sedeek et al. CLINICAL SCIENCE
- DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
- (2012) Markus L. Alter et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Effect of Benfotiamine on Advanced Glycation Endproducts and Markers of Endothelial Dysfunction and Inflammation in Diabetic Nephropathy
- (2012) Alaa Alkhalaf et al. PLoS One
- Effects of DPP-4 Inhibitors on the Heart in a Rat Model of Uremic Cardiomyopathy
- (2011) Lyubov Chaykovska et al. PLoS One
- A Double-Blind, Randomized, Placebo-Controlled Clinical Trial on Benfotiamine Treatment in Patients With Diabetic Nephropathy
- (2010) A. Alkhalaf et al. DIABETES CARE
- Sitagliptin reduces albuminuria in patients with type 2 diabetes [Rapid Communication]
- (2010) Sachiko Hattori ENDOCRINE JOURNAL
- Pharmacokinetics, pharmacodynamics and tolerability of multiple oral doses of linagliptin, a dipeptidyl peptidase-4 inhibitor in male type 2 diabetes patients
- (2009) T. Heise et al. DIABETES OBESITY & METABOLISM
- Reduction of Renal Superoxide Dismutase in Progressive Diabetic Nephropathy
- (2009) H. Fujita et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Role of reactive oxygen species in the pathogenesis of diabetic nephropathy
- (2008) Hunjoo Ha et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- NOX enzymes as novel targets for drug development
- (2008) J. David Lambeth et al. Seminars in Immunopathology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started